Quarter
Charts
πŸ‡ΊπŸ‡ΈUS Markets

CARLISLE COMPANIES INCORPORATED

CSL

CIK 0000790051 Β· Quarterly mode Β· latest period FY2026 (Q1) (ending 2026-03-31) Β· sourced from SEC EDGAR

At a glance Β· FY2026 (Q1)

Revenue
$1.05B
↓-4.0% -$44Mvs FY2025 (Q1)
Operating Income
$180M
↓-1.8% -$3Mvs FY2025 (Q1)
Net Income
$128M
↓-10.9% -$16Mvs FY2025 (Q1)
Gross Profit
$363M
↓-5.8% -$23Mvs FY2025 (Q1)

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CSL's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

6%

Trailing 3-yr CAGR was 5.9%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≀ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$355.80
Total enterprise IV
$15.37B
Diluted shares
0.04B
Terminal PV
$11.02B (72% of total)
Year-5 FCF
$1.30B
YearProjected FCFDiscounted PV
+1$1.03B$935M
+2$1.09B$901M
+3$1.16B$869M
+4$1.23B$837M
+5$1.30B$807M
Terminal$17.75B$11.02B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target β€” and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation Β· trailing 4 quarters

how the company spent its cash
Capex (TTM)
$131M
investment in PP&E
Dividends paid (TTM)
$182M
cash returned to holders
Stock buybacks (TTM)
$1.15B
share count reduction
Stock-based comp (TTM)
$33M
non-cash dilution

Recent performance Β· 68 quarters

Free Cash Flow↓-168.4% -$46M
$-73M

Drill down